In this issue:
- Vaping and smoking in NZ under-14s
- Association of e-cigarette exposure with ventilation homogeneity in young adults
- Lung function trajectories over the life course
- Reduced ICS response in current smokers with COPD, regardless of blood eosinophil count
- Airway eosinophilia linked to type 2 inflammation and ICS response in COPD
- Associations of type 2 inflammation biomarkers with response to dupilumab in COPD
- Temporal risks of nonfatal CV events after COPD exacerbations
- Associations of socioeconomic status and frailty with incident COPD
- Long-term oxygen therapy for COPD: optimised oxygenation improves functional capacity
- Morphine fails to improve chronic breathlessness
Please login below to download this issue (PDF)